ES2043605T3 - Procedimiento de preparacion de nuevos derivados del 4-morfolinil-1h-indol. - Google Patents

Procedimiento de preparacion de nuevos derivados del 4-morfolinil-1h-indol.

Info

Publication number
ES2043605T3
ES2043605T3 ES86402764T ES86402764T ES2043605T3 ES 2043605 T3 ES2043605 T3 ES 2043605T3 ES 86402764 T ES86402764 T ES 86402764T ES 86402764 T ES86402764 T ES 86402764T ES 2043605 T3 ES2043605 T3 ES 2043605T3
Authority
ES
Spain
Prior art keywords
indol
morpholinyl
procedure
preparation
new derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES86402764T
Other languages
English (en)
Inventor
Jean-Claude Gasc
Lucien Nedelec
Claude Rettien
Nanopoulos Dinah Weissmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Application granted granted Critical
Publication of ES2043605T3 publication Critical patent/ES2043605T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

LA INVENCION CONCIERNE A DERIVADOS DE 4-MORFOLINIL 1H-INDOL, ASI COMO A SUS SALES DE ADICION CON LOS ACIDOS MINERALES U ORGANICOS DE FORMULA (I): R1 ES H, ALC C1-C4; R2 ES -CH2OH, -CH2-S-ALC, -CH2CN, CARBOXI EVENTUALMENTE ESTERIFICADO O AMIDIFICADO, SU PROCEDIMIENTO DE PREPARACION, SU APLICACION A TITULO DE MEDICAMENTO, LAS COMPOSICIONES QUE LOS CONTIENEN Y LOS COMPUESTOS INTERMEDIOS.
ES86402764T 1985-12-13 1986-12-11 Procedimiento de preparacion de nuevos derivados del 4-morfolinil-1h-indol. Expired - Lifetime ES2043605T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8518482A FR2591595B1 (fr) 1985-12-13 1985-12-13 Nouveaux derives du 4-morpholinyl 1h-indole, leurs sels, procede de preparation, application a titre de medicaments, compositions les renfermant, et intermediaires

Publications (1)

Publication Number Publication Date
ES2043605T3 true ES2043605T3 (es) 1994-01-01

Family

ID=9325757

Family Applications (1)

Application Number Title Priority Date Filing Date
ES86402764T Expired - Lifetime ES2043605T3 (es) 1985-12-13 1986-12-11 Procedimiento de preparacion de nuevos derivados del 4-morfolinil-1h-indol.

Country Status (11)

Country Link
US (2) US4699907A (es)
EP (1) EP0230179B1 (es)
JP (1) JPS62148485A (es)
AT (1) ATE81127T1 (es)
CA (1) CA1266471A (es)
DE (1) DE3686876T2 (es)
ES (1) ES2043605T3 (es)
FR (1) FR2591595B1 (es)
GR (1) GR3006137T3 (es)
HU (1) HU199458B (es)
PT (1) PT83920B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264442A (en) * 1990-08-13 1993-11-23 Hoechst-Roussel Pharmaceuticals Incorporated Carbamoyl-1-(pyridinylalkyl)-1H-indoles, indolines and related analogs
DE69114210T2 (de) * 1990-08-13 1996-05-02 Hoechst Roussel Pharma Carbamoyl-1-(pyridinylalkyl)-1H-indole, -indoline und verwandte Verbindungen.
FR2792313A1 (fr) * 1999-04-13 2000-10-20 Synthelabo Derives de 2-aminoethyl-indole, leur preparation et leur application en therapeutique
EP1283199A4 (en) 2000-05-16 2003-12-17 Takeda Chemical Industries Ltd MELANIN CONCENTRATION HORMONE ANTAGONIST

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2512817A1 (fr) * 1981-09-17 1983-03-18 Roussel Uclaf Nouveaux derives de l'aminomethyl 1h-indole-4-methanol et leurs sels, leur procede de preparation, leur application a titre de medicaments, les compositions les renfermant et leurs intermediaires de preparation
FR2501208A1 (fr) * 1981-09-17 1982-09-10 Roussel Uclaf Nouveaux derives du morpholinyl-indole, leurs sels, procede et intermediaires de preparation, application a titre de medicaments et composition les renfermant

Also Published As

Publication number Publication date
GR3006137T3 (es) 1993-06-21
EP0230179A3 (en) 1988-05-18
HUT45996A (en) 1988-09-28
JPS62148485A (ja) 1987-07-02
DE3686876T2 (de) 1993-05-06
HU199458B (en) 1990-02-28
PT83920A (fr) 1987-01-01
US4736042A (en) 1988-04-05
US4699907A (en) 1987-10-13
FR2591595A1 (fr) 1987-06-19
PT83920B (pt) 1989-06-30
EP0230179A2 (fr) 1987-07-29
FR2591595B1 (fr) 1988-09-09
CA1266471A (fr) 1990-03-06
DE3686876D1 (de) 1992-11-05
EP0230179B1 (fr) 1992-09-30
ATE81127T1 (de) 1992-10-15

Similar Documents

Publication Publication Date Title
ES2054860T3 (es) Nuevos derivados de 9-halogeno-(z)-prostaglandinas, procedimiento para su preparacion, asi como a su utilizacion como medicamentos.
ES2011210T3 (es) Derivados de gem-difosfonato substituido, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ES2059317T3 (es) Tolunitrilos alfa-heterociclo-sustituidos.
ES2039278T3 (es) Procedimiento para preparar inhibidores de 5-alfa-reductasa de esteroides.
MX9300786A (es) Compuestos hipolipidaemicos.
ES2043625T3 (es) Derivados de acido ariloxicarboxilico, su preparacion y empleo.
ES2058527T3 (es) Derivados de pirimidina condensados procedimiento y compuestos intermedios para su preparacion y composiciones farmaceuticas que los contienen.
ES2053508T3 (es) Compuestos de acidos 3-pirrolidinil-tio-1-azabiciclo(3.2.0)hept-2-eno-2-carboxilicos.
PT91121A (pt) Processo para a preparacao de derivados da quinolina e de composicoes farmaceuticas que os contem
ES2045180T3 (es) Nuevo procedimiento para la obtencion de 4-aciloxi-3-hidroxietil-azetidinonas.
ES2053778T3 (es) Procedimiento para la obtencion de derivados del tiazol.
PT82097B (pt) Processo para a preparacao de derivados de labdano e de composicoes farmaceuticas que os contem
ES2051843T3 (es) Un proceso para la preparacion de un derivado del acido benzoilaminofenoxibutanico.
MX168030B (es) Procedimiento para la preparacion de derivados de alcano y alcoxialcano
ES2032752T3 (es) Procedimiento de preparacion de derivados de la 1-bencenosulfonil-2-oxo-5-alcoxi-pirrolidina.
ES2171722T3 (es) Nuevos derivados de la 5-o-desosaminil-6-o-metil-eritronolida a, su procedimiento de preparacion y su aplicacion a la preparacion de productos biologicamente activos.
ES2043863T3 (es) Procedimiento para preparar derivados de la 1,2,5,6-tetrahidropiridina.
DK421586D0 (da) Irreversible dopamin-beta-hydroxylaseinhibitorer
ES2095848T3 (es) Nuevos derivados de fosfolipidos y su utilizacion para la preparacion de medicamentos antiviricos.
ES2106936T5 (es) Derivados de carbazolona y procedimientos para su preparacion.
ES2043605T3 (es) Procedimiento de preparacion de nuevos derivados del 4-morfolinil-1h-indol.
ES2032582T3 (es) Procedimiento para preparar derivados de la oxima del 1,2,5,6,-tetrahidropiridin -3-carboxialdehido.
ES2073393T3 (es) Derivados de acidos 2,4- y 2,5-dicarboxilicos, procedimiento para su preparacion, utilizacion de los mismos asi como medicamentos a base de estos compuestos.
ES2183492T3 (es) Nuevos derivados de nitrono,su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2192263T3 (es) Derivados de benzo(c)quinolizina, su preparacion y empleo como inhibidores de 5-alfa-reductasas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 230179

Country of ref document: ES